Your browser doesn't support javascript.
loading
Efficacy and safety of intraoperative injection of mitomycin C during trabeculectomy: a systematic review and meta-analysis.
Zheng, Jing; Zhang, Ai.
Afiliação
  • Zheng J; Department of Ophthalmology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, 9 Jiaowei Road, Liuhongqiao, Wenzhou, 325000, Zhejiang, China.
  • Zhang A; Department of Ophthalmology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, 9 Jiaowei Road, Liuhongqiao, Wenzhou, 325000, Zhejiang, China. zjzj0110@163.com.
Int Ophthalmol ; 44(1): 372, 2024 Sep 06.
Article em En | MEDLINE | ID: mdl-39240391
ABSTRACT

PURPOSE:

Trabeculectomy, a primary surgical treatment for glaucoma, often employs mitomycin C (MMC) to reduce scar formation and improve surgical outcomes. However, the optimal application method of MMC, whether by injection or sponge, remains a subject of debate. This meta-analysis aims to compare injectable and sponge-based MMC application in terms of efficacy and safety, focusing on various clinical outcomes in glaucoma patients.

METHODS:

A comprehensive literature search of Scopus, MEDLINE, EMBASE, Ovid, Chinese biomedical literature database, China National Knowledge Infrastructure, and Cochrane Library was done for eligible studies that report data of glaucoma patients who were administered MMC by injection or sponge application during trabeculectomy. Outcomes of interest included intraocular pressure (IOP) reduction, bleb appearance grading (height, extent, vascularity), use of anti-glaucoma medications, and rates of complete success, qualified success, and failure. Data were reported as weighted mean differences (WMD) or odds ratios (OR) with confidence intervals (CI). The random-effects inverse-variance model with DerSimonian-Laird estimate of tau2 was employed, with continuity correction applied where necessary.

RESULTS:

A total of 15 studies with 1276 participants were included. The meta-analysis revealed no significant difference in IOP reduction between patients treated by MMC injection and sponge application (WMD = - 0.434). Significant differences were observed in bleb appearance grading scores for height (WMD = - 0.170) and extent (WMD = 0.174), with substantial heterogeneity. The use of anti-glaucoma medications was significantly lower in the injection group (WMD = - 0.274). However, there were no significant differences in the rates of complete success, qualified success, and failure. The study demonstrated moderate to high heterogeneity across various outcomes.

CONCLUSION:

This meta-analysis indicated that while both injection and sponge methods of MMC application during trabeculectomy were equally effective for IOP reduction, they differ in their impact on bleb morphology and postoperative medication requirement. The findings highlight the need for individualized treatment approaches in glaucoma surgery, taking into account the specific needs and characteristics of each patient.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trabeculectomia / Glaucoma / Mitomicina / Pressão Intraocular Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trabeculectomia / Glaucoma / Mitomicina / Pressão Intraocular Idioma: En Ano de publicação: 2024 Tipo de documento: Article